Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-22-000062
Filing Date
2022-06-24
Accepted
2022-06-24 16:30:08
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165610257799601.html 4  
1 FORM 4 wf-form4_165610257799601.xml 4 4055
  Complete submission text file 0001401914-22-000062.txt   5668
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Grossman Jessica D. (Reporting) CIK: 0001736781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 221040474